Donald Hooker
Stock Analyst at Keybanc
(2.80)
# 1,795
Out of 4,888 analysts
82
Total ratings
55.95%
Success rate
17.03%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $8.51 | +1,075.09% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $158.39 | +146.23% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $172.50 | -1.45% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $164.47 | +76.32% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $28.41 | +156.95% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $5.36 | +571.64% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $8.49 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $280.63 | +25.79% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $103.12 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $70.99 | +18.33% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $11.78 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $257.45 | -33.97% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $151.58 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $1.58 | +2,811.39% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $21.92 | - | 1 | Oct 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $322.50 | - | 2 | Jul 10, 2017 | |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $8.51
Upside: +1,075.09%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $158.39
Upside: +146.23%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $172.50
Upside: -1.45%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $164.47
Upside: +76.32%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $28.41
Upside: +156.95%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $5.36
Upside: +571.64%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $8.49
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $280.63
Upside: +25.79%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $103.12
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $70.99
Upside: +18.33%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $11.78
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $257.45
Upside: -33.97%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $151.58
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $1.58
Upside: +2,811.39%
Oct 24, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $21.92
Upside: -
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $322.50
Upside: -